On Wednesday, MFA Financial, Inc. (NYSE:MFA)’s shares inclined 1.30% to $7.82.
MFA Financial, Inc. (MFA) declared that its Board of Directors declared a regular quarterly cash dividend of $0.20 per share of common stock for the second quarter of 2015. The dividend will be paid on July 31, 2015, to stockholders of record on June 29, 2015.
MFA Financial, Inc., a real estate investment trust (REIT), invests in residential agency and non-agency mortgage-backed securities (MBS), and residential whole loans in the United States (the U.S.). Its MBS are secured by hybrid mortgages, adjustable-rate mortgages, and 15-year and longer term fixed-rate mortgages, in addition to by mortgages that have interest rates that reset more frequently.
Amgen, Inc. (NASDAQ:AMGN)’s shares dropped -0.37% to $155.65.
Amgen, Inc. (AMGN) declared that the Company will talk about the data supporting the RepathaTM (evolocumab) Biologics License Application (BLA) for the treatment of high cholesterol with the U.S. Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC). Repatha is an investigational fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that reduces the liver’s ability to remove low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, from the blood.1
At recently’s FDA advisory committee meeting, Amgen will present Repatha clinical trial data from about 6,800 patients, counting more than 4,500 patients with high cholesterol in 10 Phase 3 trials. The Phase 3 studies evaluated the efficacy and safety of Repatha in patients with elevated cholesterol, counting patients on statins with or without other lipid-lowering therapies; patients who cannot tolerate statins; patients with heterozygous familial hypercholesterolemia (HeFH) and patients with homozygous familial hypercholesterolemia (HoFH), a rare and serious genetic disorder.2
Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine.
At the end of Wednesday’s trade, Viacom, Inc. (NASDAQ:VIAB)‘s shares surged 0.09% to $66.88.
Paramount Pictures Corporation (PPC), a global producer and distributor of filmed entertainment, is a unit of Viacom, Inc. (VIAB).
To celebrate the release of the highly anticipated film “TERMINATOR GENISYS,” Paramount Pictures, Skydance Productions, Arnold Schwarzenegger and Waze (www.waze.com) have teamed up to give drivers around the world the ultimate voice navigation machine: Arnold Schwarzenegger as the ‘Guardian’ Terminator from “TERMINATOR GENISYS.”
Starting, users of the world’s largest community-based traffic and navigation app can select custom Terminator voice commands from the Terminator himself. The Terminator will give directions to user’s destinations and alert them if a T-1000 is spotted ahead. In addition, movie theater locations showing “TERMINATOR GENISYS” will be branded with the iconic red-eyed Endoskull, assisting WAZE users to see the film when it opens in theaters on July 1st, 2015.
Viacom Inc. operates as an entertainment content company in the United States and internationally. The company creates television programs, motion pictures, short-form video, applications, games, consumer products, social media, and other entertainment content.
Masco Corporation (NYSE:MAS), ended its Wednesday’s trading session with 0.26% gain, and closed at $27.45.
Masco Corporation (MAS) declared that its Board of Directors has approved the formerly-declared spin-off of TopBuild Corp. (BLD), which will, upon completion of the spin-off, hold the assets and operations of Masco’s Installation and Other Services businesses.
In the spin-off, Masco will distribute 100% of the shares of common stock of TopBuild. The distribution of TopBuild shares is predictable to be accomplished after the New York Stock Exchange market closing on June 30, 2015, with Masco stockholders receiving one share of TopBuild common stock for every nine shares of Masco common stock held at the close of business on the record date of June 19, 2015. Following the distribution of TopBuild common stock, TopBuild will be an independent, publicly-traded company. TopBuild has received approval for the listing of its common stock on the New York Stock Exchange under the symbol “BLD.”
Masco Corporation manufactures, distributes, and installs home improvement and building products worldwide. The company’s Cabinets and Related Products segment provides cabinetry for kitchen, bath, storage, home office, and home entertainment applications; and kitchen countertops, and integrated bathroom vanity and countertop solutions. Its Plumbing Products segment offers faucets, showerheads, handheld showers, valves, bathing units, and toilets; acrylic tub and shower systems, bath and shower enclosure units, shower trays, and laundry tubs, in addition to spas; and brass and copper plumbing system components, and other plumbing specialties.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
